Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.4 USD | -0.91% | +7.54% | +90.16% |
22/03 | Raymond James Starts Oscar Health With Outperform Rating, $20 Price Target | MT |
18/03 | Oscar Health, Inc.(NYSE:OSCR) added to S&P Insurance Select Industry Index | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company is in a robust financial situation considering its net cash and margin position.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.25 for the 2024 fiscal year.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+90.16% | 4.16B | - | ||
+11.81% | 9.58B | B- | ||
+0.14% | 6.39B | C+ | ||
+0.07% | 2.31B | B+ | ||
-21.34% | 1.01B | C | ||
+3.85% | 862M | - | D+ | |
+83.33% | 718M | - | C | |
+3.52% | 155M | - | - | |
-6.42% | 68.79M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- OSCR Stock
- Ratings Oscar Health, Inc.